J9316 is a valid 2023 HCPCS Code that could be used to indicate Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg for reimbursement purposes.
J9316 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2021.
Pertuzu, trastuzu, 10 mg
J9316 code information
| HCPCS code: | J9316 |
| Description: | INJECTION, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PER 10 MG |
| Effective Date: | Jan 01, 2021 |
| Added Date: | Jan 01, 2021 |
| Termination Date: | HCPCS J9316 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1D - CHEMOTHERAPY |
| Action code: | A - ADD PROCEDURE OR MODIFIER CODE |
| Type of Service: |
1 - MEDICAL CARE
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to J9316